LSI has announced that it has launched as an independent business, following the completion of the carve out of Lonza Specialty Ingredients from Lonza Group. Marc Doyle has been appointed Chief Executive Officer of LSI, effective immediately.
LSI is now held by Herens HoldCo Ltd., an entity controlled by private equity firms Bain Capital and Cinven. Commenting on the launch of LSI, Marc Doyle, chief executive officer of LSI, said: “This carve out is a transformational opportunity for LSI, enabling it to accelerate its growth strategy within the microbial control and specialty chemicals markets with the strong, long-term support of our new owners. As we continue to build on the solid foundations created by Lonza Group, independence will allow LSI to be a more responsive and agile business, developing unique, innovative solutions to help customers protect their products from microbial spoilage, improve health and safety and reduce their environmental footprints. We are also firmly committed to building and investing in LSI’s sustainability strategy, enabling the business to respond and adapt to long-term environmental and social changes that are having a significant impact on the industry.”
LSI has a global team of 2,900 experts driven by the business’s core values of performance, collaboration, passion, and care. LSI is focused on strengthening the position of both the Microbial Control Solutions (MCS) and Specialty Products Solutions (SPS) businesses through strategic M&A opportunities and internal investment, particularly in innovation and its production assets.
